0001171843-17-005277.txt : 20170828
0001171843-17-005277.hdr.sgml : 20170828
20170828205452
ACCESSION NUMBER: 0001171843-17-005277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170824
FILED AS OF DATE: 20170828
DATE AS OF CHANGE: 20170828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDENBERG DAVID M
CENTRAL INDEX KEY: 0001029578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 171055937
MAIL ADDRESS:
STREET 1: UBS GLOBAL ASSET MANAGEMENT (US) INC.
STREET 2: 51 WEST 52ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
4
1
formfour.xml
FORM 4
X0306
4
2017-08-24
0
0000722830
IMMUNOMEDICS INC
IMMU
0001029578
GOLDENBERG DAVID M
C/O IMMUNOMEDICS, INC
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
1
1
0
0
See Remarks
Common Stock
2410489
D
Common Stock
2017-08-24
4
S
0
25000
10.2442
D
3430578
I
See Footnote
Common Stock
2017-08-28
4
S
0
5000
11.45
D
3425578
I
See Footnote
Common Stock
2017-08-28
4
S
0
10000
11.5591
D
3415578
I
See Footnote
Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $10.15 to $10.31.
The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $11.55 to $11.59.
Chief Scientific Officer and Chief Patent Officer
/s/ Cynthia L. Sullivan, Attorney-In-Fact
2017-08-28